|
951
|
|
|
MAGE family member D1 |
DLXIN-1, NRAGE |
|
|
952
|
|
|
Mannose-P-dolichol utilization defect 1 |
CDGIF, HBEBP2BPA, Lec35, My008, PP3958, PQLC5, SL15, SLC66A5 |
Brachycephaly, Cerebellar atrophy, Cerebral atrophy, Cerebral cortical atrophy, Congenital disorder of glycosylation, Deficiency of glucose-6-phosphate dehydrogenase, Developmental delay, Exfoliative dermatitis, Glomerulonephritis, Hyperkeratosis, Hypothyroidism, Ichthyosis, Impaired cognition, Microcephaly, Nystagmus, Optic atrophy, StrabismusView all (2 more) |
|
953
|
|
|
Mitochondrial ribosomal protein L33 |
C2orf1, L33mt, MRP-L33, RPL33L, bL33m |
|
|
954
|
|
|
MacroH2A.1 histone |
H2A.y, H2A/y, H2AF12M, H2AFY, MACROH2A1.1, mH2A1, macroH2A1.2 |
|
|
955
|
|
|
Multiple inositol-polyphosphate phosphatase 1 |
HIPER1, MINPP2, MIPP, PCH16 |
Nonmedullary thyroid carcinoma, Arsenic encephalopathy, Colonic neoplasms, Dermatologic disorders, Follicular thyroid carcinoma, Head and neck neoplasms, Lung diseases, Nodular goiter, Papillary renal carcinoma, Papillary thyroid carcinoma, Spinal cord compression, Thyroid cancer, Thyroid carcinoma |
|
956
|
|
|
Microtubule associated monooxygenase, calponin and LIM domain containing 2 |
Ebitein1, MICAL-2, MICAL2PV1, MICAL2PV2, MICALCL, mical-cL |
|
|
957
|
|
|
Mediator of DNA damage checkpoint 1 |
NFBD1 |
|
|
958
|
|
|
Matrin 3 |
ALS21, MPD2, VCPDM |
Amyotrophic lateral sclerosis, Anxiety disorder, Bulbar palsy, Dementia, Distal muscular dystrophy, Distal upper limb amyotrophy, Dysarthria, Dysphagia, Laryngospasm, Mental depression, Mood swings, Myofibrillar myopathy, Myopathy, Partial paralysis vocal cords, Respiratory failure, Vocal cord and pharyngeal distal myopathyView all (1 more) |
|
959
|
|
|
MTSS I-BAR domain containing 1 |
MIM, MIMA, MIMB |
|
|
960
|
|
|
Mitochondrial ribosomal protein L19 |
L15mt, L19mt, MRP-L15, MRP-L19, MRPL15, RLX1, RPML15, bL19m |
|
